Načítá se...
Schizophrenia and substance use comorbidity: a genome-wide perspective
Dual diagnosis with substance use disorders (SUDs) consistently contributes to the premature mortality and increased disability observed in schizophrenia. Large genome-wide association studies are providing the information needed to investigate the genetic architecture of psychiatric disorders. Here...
Uloženo v:
| Vydáno v: | Genome Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5359801/ https://ncbi.nlm.nih.gov/pubmed/28327175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0423-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|